Literature DB >> 17119032

Body size, mammographic density, and breast cancer risk.

Norman F Boyd1, Lisa J Martin, Limei Sun, Helen Guo, Anna Chiarelli, Greg Hislop, Martin Yaffe, Salomon Minkin.   

Abstract

BACKGROUND: Greater weight and body mass index (BMI) are negatively correlated with mammographic density, a strong risk factor for breast cancer, and are associated with an increased risk of breast cancer in postmenopausal women, but with a reduced risk in premenopausal women. We have examined the associations of body size and mammographic density on breast cancer risk.
METHOD: We examined the associations of body size and the percentage of mammographic density at baseline with subsequent risk of breast cancer among 1,114 matched case-control pairs identified from three screening programs. The effect of each factor on risk of breast cancer was examined before and after adjustment for the other, using logistic regression.
RESULTS: In all subjects, before adjustment for mammographic density, breast cancer risk in the highest quintile of BMI, compared with the lowest, was 1.04 [95% confidence interval (CI), 0.8-1.4]. BMI was associated positively with breast cancer risk in postmenopausal women, and negatively in premenopausal women. After adjustment for density, the risk associated with BMI in all subjects increased to 1.60 (95% CI, 1.2-2.2), and was positive in both menopausal groups. Adjustment for BMI increased breast cancer risk in women with 75% or greater density, compared with 0%, increased from 4.25 (95% CI, 1.6-11.1) to 5.86 (95% CI, 2.2-15.6).
CONCLUSION: BMI and mammographic density are independent risk factors for breast cancer, and likely to operate through different pathways. The strong negative correlated between them will lead to underestimation of the effects on risk of either pathway if confounding is not controlled.

Entities:  

Mesh:

Year:  2006        PMID: 17119032     DOI: 10.1158/1055-9965.EPI-06-0345

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  107 in total

Review 1.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.

Authors:  Valerie A McCormack; Anya Burton; Isabel dos-Santos-Silva; John H Hipwell; Caroline Dickens; Dorria Salem; Rasha Kamal; Mikael Hartman; Charmaine Pei Ling Lee; Kee-Seng Chia; Vahit Ozmen; Mustafa Erkin Aribal; Anath Arzee Flugelman; Martín Lajous; Ruy Lopez-Riduara; Megan Rice; Isabelle Romieu; Giske Ursin; Samera Qureshi; Huiyan Ma; Eunjung Lee; Carla H van Gils; Johanna O P Wanders; Sudhir Vinayak; Rose Ndumia; Steve Allen; Sarah Vinnicombe; Sue Moss; Jong Won Lee; Jisun Kim; Ana Pereira; Maria Luisa Garmendia; Reza Sirous; Mehri Sirous; Beata Peplonska; Agnieszka Bukowska; Rulla M Tamimi; Kimberly Bertrand; Chisato Nagata; Ava Kwong; Celine Vachon; Christopher Scott; Beatriz Perez-Gomez; Marina Pollan; Gertraud Maskarinec; Graham Giles; John Hopper; Jennifer Stone; Nadia Rajaram; Soo-Hwang Teo; Shivaani Mariapun; Martin J Yaffe; Joachim Schüz; Anna M Chiarelli; Linda Linton; Norman F Boyd
Journal:  Cancer Epidemiol       Date:  2015-12-24       Impact factor: 2.984

3.  The effect of change in body mass index on volumetric measures of mammographic density.

Authors:  Vicki Hart; Katherine W Reeves; Susan R Sturgeon; Nicholas G Reich; Lynnette Leidy Sievert; Karla Kerlikowske; Lin Ma; John Shepherd; Jeffrey A Tice; Amir Pasha Mahmoudzadeh; Serghei Malkov; Brian L Sprague
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-27       Impact factor: 4.254

Review 4.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

5.  Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

Authors:  Kayoung Lee; Jung Eun Yoo; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  Horm Cancer       Date:  2018-07-24       Impact factor: 3.869

6.  Breast cancer risk prediction using a clinical risk model and polygenic risk score.

Authors:  Yiwey Shieh; Donglei Hu; Lin Ma; Scott Huntsman; Charlotte C Gard; Jessica W T Leung; Jeffrey A Tice; Celine M Vachon; Steven R Cummings; Karla Kerlikowske; Elad Ziv
Journal:  Breast Cancer Res Treat       Date:  2016-08-26       Impact factor: 4.872

7.  Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Hanna Bandos; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-11

8.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

9.  Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.

Authors:  Deborah J Thompson; Martin O Leach; Gek Kwan-Lim; Simon A Gayther; Susan J Ramus; Iqbal Warsi; Fiona Lennard; Michael Khazen; Emilie Bryant; Sadie Reed; Caroline R M Boggis; D Gareth Evans; Rosalind A Eeles; Douglas F Easton; Ruth M L Warren
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

10.  Active, but not passive cigarette smoking was inversely associated with mammographic density.

Authors:  Lesley M Butler; Ellen B Gold; Shannon M Conroy; Carolyn J Crandall; Gail A Greendale; Nina Oestreicher; Charles P Quesenberry; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2010-02       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.